Paper31409554
The isothiocyanate sulforaphane inhibits mTOR in an NRF2-independent manner.
Zhang Y and 4 others. Phytomedicine, 2021. Cited by 33 papers, by iCite.
Cite this record
ConductScience Library. The isothiocyanate sulforaphane inhibits mTOR in an NRF2-independent manner. Papers, record 31409554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31409554
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Isothiocyanates | Major topic |
| NF-E2-Related Factor 2 | Major topic |
| Sulfoxides | Major topic |
| TOR Serine-Threonine Kinases | Major topic |
| Animals | |
| Cell Line, Tumor | |
| Humans | |
| Phosphatidylinositol 3-Kinases | |
| Phosphorylation | |
| Proto-Oncogene Proteins c-akt |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 10270 | Cancer Research UK | United Kingdom | PubMed | |
| 18644 | Cancer Research UK | United Kingdom | PubMed | |
| 22869 | Cancer Research UK | United Kingdom | PubMed |
Source PubMed
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25323681 | Suppression of feedback loops mediated by PI3K/mTOR induces multiple overactivation of compensatory pathways: an unintended consequence leading to drug resistance. | Mol Cancer Ther | 2014 | https://conductscience.org/library/papers/25323681 | PubMed |
| 2 | 16280330 | Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells. | Carcinogenesis | 2006 | https://conductscience.org/library/papers/16280330 | PubMed |
| 3 | 27075683 | A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet. | Sci Rep | 2016 | https://conductscience.org/library/papers/27075683 | PubMed |
| 4 | 24322890 | Sulphoxythiocarbamates modify cysteine residues in HSP90 causing degradation of client proteins and inhibition of cancer cell proliferation. | Br J Cancer | 2014 | https://conductscience.org/library/papers/24322890 | PubMed |
| 5 | 28692050 | Crosstalk between NRF2 and HIPK2 shapes cytoprotective responses. | Oncogene | 2017 | https://conductscience.org/library/papers/28692050 | PubMed |
| 6 | 29242678 | KEAP1 and Done? Targeting the NRF2 Pathway with Sulforaphane. | Trends Food Sci Technol | 2017 | https://conductscience.org/library/papers/29242678 | PubMed |
| 7 | 30856464 | Sulforaphane triggers a functional elongation of microglial process via the Akt signal. | J Nutr Biochem | 2019 | https://conductscience.org/library/papers/30856464 | PubMed |
| 8 | 22640870 | Sulforaphane, a cruciferous vegetable-derived isothiocyanate, inhibits protein synthesis in human prostate cancer cells. | Biochim Biophys Acta | 2012 | https://conductscience.org/library/papers/22640870 | PubMed |
| 9 | 17914583 | Sulforaphane induces cell cycle arrest and apoptosis in murine osteosarcoma cells in vitro and inhibits tumor growth in vivo. | Oncol Rep | 2007 | https://conductscience.org/library/papers/17914583 | PubMed |
| 10 | 17643370 | HDAC6 modulates cell motility by altering the acetylation level of cortactin. | Mol Cell | 2007 | https://conductscience.org/library/papers/17643370 | PubMed |
| 11 | 17287208 | Phosphorylation of beta-catenin by AKT promotes beta-catenin transcriptional activity. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17287208 | PubMed |
| 12 | 14585973 | Distinct cysteine residues in Keap1 are required for Keap1-dependent ubiquitination of Nrf2 and for stabilization of Nrf2 by chemopreventive agents and oxidative stress. | Mol Cell Biol | 2003 | https://conductscience.org/library/papers/14585973 | PubMed |
| 13 | 8910387 | Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. | J Biol Chem | 1996 | https://conductscience.org/library/papers/8910387 | PubMed |
| 14 | 16571651 | Sulforaphane enhances TRAIL-induced apoptosis through the induction of DR5 expression in human osteosarcoma cells. | Carcinogenesis | 2006 | https://conductscience.org/library/papers/16571651 | PubMed |
| 15 | 10567225 | Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. | Biochem J | 1999 | https://conductscience.org/library/papers/10567225 | PubMed |
| 16 | 28212891 | Sulforaphane inhibits platelet-derived growth factor-induced vascular smooth muscle cell proliferation by targeting mTOR/p70S6kinase signaling independent of Nrf2 activation. | Pharmacol Res | 2017 | https://conductscience.org/library/papers/28212891 | PubMed |
| 17 | 17347138 | Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast. | Carcinogenesis | 2007 | https://conductscience.org/library/papers/17347138 | PubMed |
| 18 | 23254561 | Effectiveness of sulforaphane as a radiosensitizer for murine osteosarcoma cells. | Oncol Rep | 2013 | https://conductscience.org/library/papers/23254561 | PubMed |
| 19 | 24405297 | Sulforaphane induces DNA damage and mitotic abnormalities in human osteosarcoma MG-63 cells: correlation with cell cycle arrest and apoptosis. | Nutr Cancer | 2014 | https://conductscience.org/library/papers/24405297 | PubMed |
| 20 | 7826396 | Reversible conjugation of isothiocyanates with glutathione catalyzed by human glutathione transferases. | Biochem Biophys Res Commun | 1995 | https://conductscience.org/library/papers/7826396 | PubMed |
Cited by30
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42939845 | Sulforaphane as a Therapeutic Target for Sarcopenia in Type 2 Diabetes: Mechanistic Insights and Translational Evidence. | Antioxidants (Basel) | 2026 | https://conductscience.org/library/papers/42939845 | PubMed |
| 42821033 | Machine learning for discovering anticancer compounds from plants and elucidating their mechanisms. | J Comput Aided Mol Des | 2026 | https://conductscience.org/library/papers/42821033 | PubMed |
| 42654274 | Sulforaphane Decreases the Burden of AKT1-Expressing Pre-Neoplastic Cells in a Zebrafish Model of Glioblastoma Initiation. | Nutrients | 2026 | https://conductscience.org/library/papers/42654274 | PubMed |
| 42653741 | Sulforaphane and Broccoli-Derived Preparations in Obesity and Obesity-Related Metabolic Dysfunction: Mechanistic Insights, Preclinical Evidence, and Clinical Perspectives. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42653741 | PubMed |
| 42123607 | Sulforaphane-Activated Functional Nucleic Acids for Cancer Therapy: Mechanisms, Delivery Strategies, and Nanomedicine Advances. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42123607 | PubMed |
| 41837504 | Targeting the mTOR Pathway with Natural Products: A Potential Therapeutic Approach for Autism Spectrum Disorders. | Curr Neuropharmacol | 2026 | https://conductscience.org/library/papers/41837504 | PubMed |
| 41768239 | Manganese modulates hepatocellular carcinoma cytotoxicity and doxorubicin sensitivity in a dose dependent manner. | Front Oncol | 2026 | https://conductscience.org/library/papers/41768239 | PubMed |
| 41275316 | Investigating the clinical efficacy, safety and molecular mechanism of sulforaphane in autism spectrum disorder: an integrated study combining meta-analysis, network pharmacology, and computational biology. | BMC Pharmacol Toxicol | 2025 | https://conductscience.org/library/papers/41275316 | PubMed |
| 41196460 | Sulforaphane: a natural organosulfur having potential to modulate apoptosis and survival signalling in cancer. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41196460 | PubMed |
| 40676702 | The dual role of mTOR signaling in lung development and adult lung diseases. | Cell Biosci | 2025 | https://conductscience.org/library/papers/40676702 | PubMed |
| 39765789 | The Effect of Moringa oleifera Leaf Extract on C2C12 Myoblast Proliferation and Redox Status Under Oxidative Insult. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/39765789 | PubMed |
| 39334742 | Multiple Mechanisms of Action of Sulfodyne®, a Natural Antioxidant, against Pathogenic Effects of SARS-CoV-2 Infection. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/39334742 | PubMed |
| 39199250 | Activation of Nrf2 at Critical Windows of Development Alters Tissue-Specific Protein S-Glutathionylation in the Zebrafish (Danio rerio) Embryo. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/39199250 | PubMed |
| 39139965 | Sulforaphane and ophthalmic diseases. | Food Sci Nutr | 2024 | https://conductscience.org/library/papers/39139965 | PubMed |
| 39125678 | Comparative Metabolomic Analysis of Moringa oleifera Leaves of Different Geographical Origins and Their Antioxidant Effects on C2C12 Myotubes. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39125678 | PubMed |
| 38902597 | Potential mechanisms of cancer prevention and treatment by sulforaphane, a natural small molecule compound of plant-derived. | Mol Med | 2024 | https://conductscience.org/library/papers/38902597 | PubMed |
| 38868980 | Sulforaphane enhanced muscle growth by promoting lipid oxidation through modulating key signaling pathways. | Biosci Rep | 2024 | https://conductscience.org/library/papers/38868980 | PubMed |
| 36838876 | mTOR Signaling Disruption and Its Association with the Development of Autism Spectrum Disorder. | Molecules | 2023 | https://conductscience.org/library/papers/36838876 | PubMed |
| 36500494 | The Multiple Sclerosis Modulatory Potential of Natural Multi-Targeting Antioxidants. | Molecules | 2022 | https://conductscience.org/library/papers/36500494 | PubMed |
| 36284193 | Synthesis and Anti-Inflammatory Activity of 2-Amino-4,5,6,7-tetrahydrobenzo[b]thiophene-Derived NRF2 Activators. | ChemistryOpen | 2022 | https://conductscience.org/library/papers/36284193 | PubMed |
Genes15
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31409554
GET https://conductscience.org/api/papers/v1/31409554/references?page=2